Gary Wing Kin Wong

Gary Wing Kin Wong

Auto-generated profile, based on publicly available information

Gary Wing Kin Wong

Department of Paediatrics, Prince of Wales Hospital The Chinese University of Hong Kong Hong Kong China

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
XLXiaoxia Lu
Xiaoxia Lu
LZLiqiong Zhang
Liqiong Zhang
HDHui Du
Hui Du
JZJingjing Zhang
Jingjing Zhang
YLYuan Y. Li
Yuan Y. Li
GWGary W.K. Wong
Gary W.K. Wong
As of March 10, 2020, the 2019 novel coronavirus (SARS-CoV-2) has been responsible for more than 110,000 infections and 4000 deaths worldwide, but data regarding the epidemiologic characteristics and clinical features of infected children are limited.1-3 A recent review of 72,314 cases by the Chinese Center for Disease Control and Prevention showed that less than 1% of the cases were in children younger than 10 years of age.2 In order to determine the spectrum of disease in children, we evaluated children infected with SARS-CoV-2 and treated at the Wuhan Children’s Hospital, the only center assigned by the central government for treating infected children under 16 years of age in Wuhan. Both symptomatic and asymptomatic children with known contact with persons having confirmed or suspected SARS-CoV-2 infection were evaluated. Nasopharyngeal or throat swabs were obtained for detection of SARS-CoV-2 RNA by established methods.4 The clinical outcomes were monitored up to March 8, 2020.

12 March 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Open access
PDF file
SHSusanne Halken
Susanne Halken
AMAntonella Muraro
Antonella Muraro
DSDebra de Silva
Debra de Silva
EKEkaterina Khaleva
Ekaterina Khaleva
EAElizabeth Angier
Elizabeth Angier
EGEuropean Academy of Allergy and Clinical Immunology Food Allergy and Anaphylaxis Guidelines Group
European Academy of Allergy and Clinical Immunology Food Allergy and Anaphylaxis Guidelines Group
Background: This guideline from the European Academy of Allergy and Clinical Immunology (EAACI) recommends approaches to prevent the development of immediate‐onset / IgE‐mediated food allergy in infants and young children. It is an update of a 2014 EAACI guideline.Methods: The guideline was developed using the AGREE II framework and the GRADE approach. An international Task Force with representatives from 11 countries and different disciplinary and clinical backgrounds systematically reviewed research and considered expert opinion. Recommendations were created by weighing up benefits and harms, considering the certainty of evidence and examining values, preferences and resource implications. The guideline was peer‐reviewed by external experts, and feedback was incorporated from public consultation.Results: All of the recommendations about preventing food allergy relate to infants (up to 1 year) and young children (up to 5 years), regardless of risk of allergy. There was insufficient evidence about preventing food allergy in other age groups. The EAACI Task Force suggests avoiding the use of regular cow's milk formula as supplementary feed for breastfed infants in the first week of life. The EAACI Task Force suggests introducing well‐cooked, but not raw egg or uncooked pasteurized, egg into the infant diet as part of complementary feeding. In populations where there is a high prevalence of peanut allergy, the EAACI Task Force suggests introducing peanuts in an age‐appropriate form as part of complementary feeding. According to the studies, it appears that the most effective age to introduce egg and peanut is from four to 6 months of life. The EAACI Task Force suggests against the following for preventing food allergy: (i) avoiding dietary food allergens during pregnancy or breastfeeding; and (ii) using soy protein formula in the first 6 months of life as a means of preventing food allergy. There is no recommendation for or against the following: use of vitamin supplements, fish oil, prebiotics, probiotics or synbiotics in pregnancy, when breastfeeding or in infancy; altering the duration of exclusive breastfeeding; and hydrolysed infant formulas, regular cow's milk–based infant formula after a week of age or use of emollients.Conclusions: Key changes from the 2014 guideline include suggesting (i) the introduction of peanut and well‐cooked egg as part of complementary feeding (moderate certainty of evidence) and (ii) avoiding supplementation with regular cow's milk formula in the first week of life (low certainty of evidence). There remains uncertainty in how to prevent food allergy, and further well‐powered, multinational research using robust diagnostic criteria is needed.

10 October 2023 in Allergy
Verified
Journal Article
Closed access
Marek JutelMarek Jutel
Marek Jutel
IAIoana Agache
Ioana Agache
Magdalena Zemelka-WiacekMagdalena Zemelka-Wiacek
Magdalena Zemelka-Wiacek
MAMubeccel Akdis
Mubeccel Akdis
TCTomás Chivato
Tomás Chivato
CACezmi A. Akdis
Cezmi A. Akdis

1 June 2020 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
YXYuhan Xing
Yuhan Xing
WNWei Ni
Wei Ni
QWQin Wu
Qin Wu
WLWen-Jie Li
Wen-Jie Li
GLGuo-Ju Li
Guo-Ju Li
QXQuansheng Xing
Quansheng Xing
To determine the dynamic changes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in respiratory and fecal specimens in children with coronavirus disease 2019 (COVID-19). From January 17, 2020 to February 23, 2020, three paediatric cases of COVID-19 were reported in Qingdao, Shandong Province, China. Epidemiological, clinical, laboratory, and radiological characteristics and treatment data were collected. Patients were followed up to March 10, 2020, and dynamic profiles of nucleic acid testing results in throat swabs and fecal specimens were closely monitored. Clearance of SARS-CoV-2 in respiratory tract occurred within two weeks after abatement of fever, whereas viral RNA remained detectable in stools of pediatric patients for longer than 4 weeks. Two children had fecal SARS-CoV-2 undetectable 20 days after throat swabs showing negative, while that of another child lagged behind for 8 days. SARS-CoV-2 may exist in children's gastrointestinal tract for a longer time than respiratory system. Persistent shedding of SARS-CoV-2 in stools of infected children raises the possibility that the virus might be transmitted through contaminated fomites. Massive efforts should be made at all levels to prevent spreading of the infection among children after reopening of kindergartens and schools.

2 April 2020 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
CCChris R. Carlsten
Chris R. Carlsten
SSSundeep Salvi
Sundeep Salvi
GWGary W.K. Wong
Gary W.K. Wong
KCKian Fan Chung
Kian Fan Chung
As global awareness of air pollution rises, so does the imperative to provide evidence-based recommendations for strategies to mitigate its impact. While public policy has a central role in reducing air pollution, exposure can also be reduced by personal choices. Qualified evidence supports limiting physical exertion outdoors on high air pollution days and near air pollution sources, reducing near-roadway exposure while commuting, utilising air quality alert systems to plan activities, and wearing facemasks in prescribed circumstances. Other strategies include avoiding cooking with solid fuels, ventilating and isolating cooking areas, and using portable air cleaners fitted with high-efficiency particulate air filters. We detail recommendations to assist providers and public health officials when advising patients and the public regarding personal-level strategies to mitigate risk imposed by air pollution, while recognising that well-designed prospective studies are urgently needed to better establish and validate interventions that benefit respiratory health in this context.

1 January 2014 in World Allergy Organization Journal
Verified
Journal Article
Open access
PDF file
KAKatrina Allen
Katrina Allen
PTPaul Turner
Paul Turner
RPRuby Pawankar
Ruby Pawankar
STSteve Taylor
Steve Taylor
SSScott Sicherer
Scott Sicherer
HSHugh A. Sampson
Hugh A. Sampson
Food allergy appears to be on the rise with the current mainstay of treatment centred on allergen avoidance. Mandatory allergen labelling has improved the safety of food for allergic consumers. However an additional form of voluntary labelling (termed precautionary allergen labelling) has evolved on a wide range of packaged goods, in a bid by manufacturers to minimise risk to customers, and the negative impact on business that might result from exposure to trace amounts of food allergen present during cross-contamination during production. This has resulted in near ubiquitous utilisation of a multitude of different precautionary allergen labels with subsequent confusion amongst many consumers as to their significance. The global nature of food production and manufacturing makes harmonisation of allergen labelling regulations across the world a matter of increasing importance. Addressing inconsistencies across countries with regards to labelling legislation, as well as improvement or even banning of precautionary allergy labelling are both likely to be significant steps forward in improved food safety for allergic families. This article outlines the current status of allergen labelling legislation around the world and reviews the value of current existing precautionary allergen labelling for the allergic consumer. We strongly urge for an international framework to be considered to help roadmap a solution to the weaknesses of the current systems, and discuss the role of legislation in facilitating this.